摘要
第21届欧洲血液学会年会在多发性骨髓瘤的基础研究、疾病诊治方面都取得了令人振奋的进展.年会上特别将冒烟型骨髓瘤作为一个专题来讲解,从其定义到进展的高危因素以及当前对冒烟型骨髓瘤理念的转变作了详细的阐述.
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder.There have been many advances in the diagnosis,prognosis and management of multiple myeloma at the 21th European Hematology Association Annual Meeting,especially SMM being discussed as a topic.These include a revised disease definition,new prognostic factors and new treatment options.
出处
《白血病.淋巴瘤》
CAS
2016年第8期454-456,460,共4页
Journal of Leukemia & Lymphoma
关键词
冒烟型骨髓瘤
高危因素
治疗
Smoldering multiple myeloma
Risk factors
Treatment